ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "macrophages"

  • Abstract Number: 1131 • ACR Convergence 2025

    Variant Drives Tophus Formation through Dual Mechanisms: Extracellular Aggregation andvImpaired Macrophage Phagocytic Clearance

    Yuqi wang1, Lingjiang Zhu1, Jinshuo Han2, Junbin Qian3, Martin Herrmann4, Jing Xue1 and Lei Liu1, 1The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China (People's Republic), 2Zhejiang University, School of Medicine, Hangzhou, China (People's Republic), 3Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China (People's Republic), 4University Hospital Erlangen, Erlangen, Germany

    Background/Purpose: While aggregated neutrophil extracellular traps (aggNETs) constitute the primary structural component of tophi, the susceptible population for tophaceous gout remains poorly characterized. We investigated…
  • Abstract Number: 0051 • ACR Convergence 2025

    Spp1+ Macrophages Are Specifically Enriched in Arthritic Joints and Associated with Abnormal Bone Metabolism in Collagen-Induced Arthritis Mice

    Chenjia He, Xuyang Xia, Heng Xu, Geng Yin and Qibing Xie, West China Hospital, Sichuan University, Chengdu, China (People's Republic)

    Background/Purpose: Synovial fluid (SF) of RA patients contains unique SPP1+ macrophages that drive pathogenesis by activating fibroblast-like synoviocytes (FLS). Single-cell RNA sequencing (scRNA-seq) data from…
  • Abstract Number: 2582 • ACR Convergence 2025

    Inflammatory Cell Death and Impaired Efferocytosis Drive Monocyte and Macrophage Dysfunction in VEXAS Syndrome.

    Paul Breillat1, Samuel Magaziner2, Stéphane Camus3, Lea Dionet4, Quentin Delcros5, Federica Pallotti6, Kevin Chevalier5, Margot Poux7, Olivia Lenoir8, Pierre-Louis Tharaux5, Olivier Kosmider9, David Beck10 and Benjamin Terrier11, 1INSERM, PARIS 17, Ile-de-France, France, 2Center for Human Genetics and Genomics, NYU Grossman School of Medicine, New York, NY, USA., New York, NY, 3Université de Paris, INSERM UMR970, Paris Cardiovascular Research Center, Paris, France., PARIS, France, 4INSERM, Paris, France, 5Paris Cardiovascular Research Center, Université Paris Cité, INSERM U970, Paris, France, PARIS, France, 6Internal Medicine and Clinical Immunology, Rennes, France, 7Université de Paris, PARIS 04EME, France, 8Paris Cardiovascular Research Center, Université Paris Cité, INSERM U970, Paris, France, PARIS, Ile-de-France, France, 9AP-HP, Hopital Cochin, Institut Cochin, CNRS UMR8104, INSERM U1016 Université Paris Cité Paris France., PARIS, France, 10Center for Human Genetics and Genomics, NYU Grossman School of Medicine. Division of Rheumatology, Department of Medicine, NYU Grossman School of Medicine. Department of Biochemistry and Molecular Pharmacology, NYU Grossman School of Medicine, New York, NY, USA, New York, NY, 11Cochin Hospital, Paris, France

    Background/Purpose: VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) is a life-threatening systemic disorder characterized by inflammation and increased risk of opportunistic infections. VEXAS results from…
  • Abstract Number: 0974 • ACR Convergence 2025

    Tissue resident macrophages derived from induced pluripotent stem cells induce tissue fibrosis in human skin equivalent models of systemic sclerosis

    Xuezhi Hong1, Yanhua Xiao2, shihao zhu3, Yi-Nan Li4, Linlin Huang3, Martin Regensburger5, Franz Marxreiter6, Tim Filla7, Andrea-Hermina Györfi8, James Adjaye9, Jürgen Winkler6, Florian Groeber-Becker10, Jörg Distler11 and Alexandru-Emil Matei12, 1Department of Rheumatology, University Hospital Dusseldorf, Medical Faculty of Heinrich Heine University, Dusseldorf, Germany, Düsseldorf, Germany, 2Medical Faculty of Heinrich Heine University, Dusseldorf, Germany, 3Hiller Research Center, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, Düsseldorf, Germany, 4University Hospital of Düsseldorf, Düsseldorf, Germany, 5Department of Stem Cell Biology, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany, Erlangen, Germany, 6Department of Molecular Neurology, FAU Erlangen-Nürnberg, Erlangen, Germany, Erlangen, Germany, 7Department of Rheumatology, University Hospital Düsseldorf, Medical Faculty of Heinrich-Heine University. Hiller Research Center, University Hospital Düsseldorf, Medical Faculty of Heinrich-Heine University., Düsseldorf, Germany, 8Department of Rheumatology, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University., Düsseldorf, Germany, 9Institute for Stem Cell Research and Regenerative Medicine, University Hospital Düsseldorf, Moorenstrasse 5, D-40225 Duesseldorf, Germany, Dusseldorf, Germany, 10Department of Ophthalmology, University Hospital Düsseldorf, 40225, Düsseldorf, Germany, Dusseldorf, Germany, 11University Hospital Duesseldorf and HHU, Duesseldorf, Germany, 12Department of Rheumatology, University Hospital Düsseldorf, Medical Faculty of Heinrich-Heine University. Hiller Research Center, University Hospital Düsseldorf, Medical Faculty of Heinrich-Heine University. Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, and Fraunhofer Cluster of Excellence for Immune Mediated Diseases CIMD, Frankfurt am Main, Germany, Düsseldorf, Germany

    Background/Purpose: Previous studies showed that monocyte-derived macrophages become pro-fibrotic in systemic sclerosis (SSc) and contribute to fibroblast activation. Macrophages are, however, a heterogeneous population. Macrophages…
  • Abstract Number: 0043 • ACR Convergence 2025

    Single-cell and Spatial Transcriptomic Profiling of Muscle Reveals Inflammatory Mechanisms in Anti-glycyl tRNA Synthetase Syndrome

    Takuya Harada1, Hiroyuki Yamashita1, Ami Isoda1, Ken Kawaue1, Mayuko Hayashi1, Yutaro Misawa1, Aruto Yamamoto1, Miyu Wakatsuki1, Yuya Akiyama1, Setsuko Oyama1, Kyoko Motomura1, Hiroyuki Takahashi1, Akiko Mitsuo2, Yuichi Goto3, Eisei Noiri3 and Hiroshi Kaneko1, 1Division of Rheumatic Diseases, National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, Japan, 2Division of Clinical Laboratory Medicine, National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, Japan, 3National Center Biobank Network, Tokyo, Japan

    Background/Purpose: We characterized the spatial distribution of immune cells and identified hub genes within activated molecular networks in key immune cell populations, based on the…
  • Abstract Number: 2464 • ACR Convergence 2025

    IMC-002 (IMM0306), a First-in-Class Bi-specific Fusion Protein, Demonstrates Improvements in Systemic Lupus Erythematosus (SLE) Disease Activity Measures and Biomarkers in Patients with Moderate to Severe Active SLE in the Open-label Phase 1b/2 Study

    Haihong Yao1, Wenzhi Tian2, Qian Zheng2, Min Chen2, Guoping Jiang3, Zhichun Liu4, Yingkun Nie5, Rui Wu6, Zhaohui Zheng7 and Zhanguo Li1, 1Peking University People's Hospital, Beijing, China (People's Republic), 2ImmuneCare Biopharmaceuticals (Shanghai) Co.,Ltd, Shanghai, China (People's Republic), 3Jilin Province People's Hospital, Changchun, China (People's Republic), 4The Second Affiliated Hospital of Soochow, Suzhou, China (People's Republic), 5The Second Affiliated Hospital of Harbin Medical University, Haerbin, China (People's Republic), 6The First Affiliated Hospital of Nanchang University, Nanchang, China (People's Republic), 7The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China (People's Republic)

    Background/Purpose: Deep B cell depletion has been confirmed to be the main mechanism for complete clinical response of SLE patients. We analyzed the peripheral blood…
  • Abstract Number: 0973 • ACR Convergence 2025

    Effects of a Novel Hybrid Protein Based on S100 on Macrophage Polarization and Its Therapeutic Efficacy in a Bleomycin-Induced Systemic Sclerosis Mouse Model.

    Takuya Kotani1, Takayasu Suzuka2, Shogo Matsuda3 and Tohru Takeuchi4, 1Division of Rheumatology, Department of Internal Medicine IV, Osaka Medical and Pharmaceutical University, Osaka, Japan, 2Division of Rheumatology, Department of Internal Medicine IV, Osaka Medical and Pharmaceutical University, Takatsuki, Japan, 3Department of Internal Medicine IV, Division of Rheumatology, Osaka Medical and Pharmaceutical University, Osaka, Japan, 4Department of Internal Medicine (IV), Osaka Medical and Pharmaceutical University, Takatsuki, Japan

    Background/Purpose: S100 proteins are involved in the inflammatory responses of autoimmune diseases. We previously showed that S100 proteins regulate macrophage function via CD68. Based on…
  • Abstract Number: 2078 • ACR Convergence 2025

    Neutrophil Extracellular Traps from Patients with Idiopathic Inflammatory Myopathies Induce Interferogenic Responses in Macrophages and Myeloid Dendritic Cells

    Yatzil Reyna Juárez1, Jennifer Tiaré Balderas Miranda2, Beatriz Alcalá Carmona3, María José Ostos Prado4, karina santana5, Diana Gómez-Martín6 and Jiram Torres Ruiz7, 1Instituto Politècnico Nacional, Tultitlán de Mariano Escobedo, Mexico State, Mexico, 2Universidad Nacional Autónoma de México, Coyoacán, Federal District, Mexico, 3INCMNSZ, Cdmx, Distrito Federal, Mexico, 4Instituto Nacional De Ciencias Médicas Y Nutrición Salvador Zubirán, Mexico City, Distrito Federal, Mexico, 5INCMNSZ, Ciudad de México, Federal District, Mexico, 6INCMNSZ, Mexico city, Federal District, Mexico, 7INCMNSZ, Mexico, Federal District, Mexico

    Background/Purpose: Dermatomyositis (DM) and anti-synthetase syndrome (AS) are idiopathic inflammatory myopathies (IIM) with perifascicular pathology involving vasculopathy, macrophages, dendritic cells and an overexpression of interferon-stimulated…
  • Abstract Number: 0963 • ACR Convergence 2025

    Increased expression of M2 pro-fibrotic markers in circulating monocytes and cultured monocyte-derived macrophages from systemic sclerosis patients with progressive interstitial lung disease (ILD)

    Vanessa Smith1, Stefano Soldano2, Rosanna Campitiello3, Emanuele Gotelli3, Paola Montagna4, Tamara Vojinovic4, Sabrina Paolino2, Carmen Pizzorni2, Alberto Sulli2 and Maurizio Cutolo5, 1Ghent University Hospital, Gent, Belgium, 2University of Genoa, Genova, Italy, 3University of Genoa, Genoa, Liguria, Italy, 4University of Genoa, Genova, 5University of Genova, Genova, Italy

    Background/Purpose: In the complex pathogenesis of systemic sclerosis (SSc), macrophages are mainly involved in mechanism of progressive tissue fibrosis of skin and internal organs, particularly…
  • Abstract Number: 2011 • ACR Convergence 2025

    A Phase 1 placebo controlled, single (SAD) and multiple dose escalation (MAD) safety and pharmacokinetic (PK) study of a novel colchicine analogue ABP-745 in healthy volunteers (HV)

    ullrich schwertschlag1, Roy Wu2, yan yang3 and William Shi4, 1Atom Therapeutics, PALO ALTO, CA, 2Atom Bioscience, San Francisco, CA, 3Atom Therapeutics, Suzhou, China (People's Republic), 4Atom Therapeutics, Newark, CA

    Background/Purpose: ABP-745 is a novel colchicine analogue in development as an anti-inflammatory agent for the treatment of acute gout and other chronic inflammatory conditions. In…
  • Abstract Number: 0945 • ACR Convergence 2025

    Nerve Injury-Induced Protein-1 (Ninj1) Deficiency Aggravates Murine Lupus Through Modulation of Macrophage Polarization

    Jorge Romo-Tena1, Luz Blanco2, Shuichiro Nakabo3, Victoria Hoffman4, Norio Hanata5, Mingzeng Zhang2, Carmelo Carmona-Rivera5, Eduardo Patino-Martinez6, Dillon Claybaugh2, Zu-Xi Yu2 and Mariana Kaplan5, 1Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD, 2NIH, Bethesda, MD, 3NIAMS, NIH, Bethesda, MD, 4Diagnostic and Research Services Branch, Division of Veterinary Resources, Office of Research Services, National Institutes of Health, Bethesda, MD, Bethesda, 5Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, Bethesda, MD, 6NIH/NIAMS, Bethesda, MD

    Background/Purpose: Nerve injury-induced protein-1 (Ninj1) is an adhesion molecule that plays various roles in immune and stromal cells, including the modulation of inflammation and a…
  • Abstract Number: 1870 • ACR Convergence 2025

    Paracrine WNT Signaling Modulates Profibrotic Macrophage Metabolic Activation in Systemic Sclerosis

    emily Morris1, Helen Jarnagin1, Chen-Yu Wang1, Michael Whitfield2 and Patricia Pioli3, 1Dartmouth College, Lebanon, NH, 2Geisel School of Medicine, Lebanon, NH, 3Geisel School of Medicine at Dartmouth, Lebanon, NH

    Background/Purpose: An immune fibrotic axis consisting of activated macrophages (MØs) and fibroblasts has been identified in autoimmune systemic sclerosis (SSc) that drives disease across affected…
  • Abstract Number: 0940 • ACR Convergence 2025

    Resident Macrophages Localize Near Fibroblasts and Drive Reprogramming in Lupus Nephritis Through Direct and Soluble Signaling

    Chirag Raparia1, Paul Hoover2, Arnon Arazi3, Nir Hacohen4 and Anne Davidson1, 1Feinstein Institutes for Medical Research, Manhasset, NY, 2Brigham and Women's Hospital, Boston, MA, 3Feinstein Institutes for Medical Research, Acton, MA, 4Broad Institute of MIT Harvard, Cambridge, MA

    Background/Purpose: Lupus nephritis (LN) is a severe manifestation of SLE that can progress to renal fibrosis, and eventual renal failure. In LN, tubulointerstitial inflammation and…
  • Abstract Number: 1844 • ACR Convergence 2025

    Disease-Associated Macrophages Express an Injury-Associated Gene Program and Localize to Distinct Compartments in Proliferative and Mixed Histologic Classes of Lupus Nephritis

    Paul Hoover1, Rollin Leavitt2, Jill Buyon3, Jennifer Anolik4, Jennifer Barnas5, Judith James6, Joel Guthridge6, Michelle Petri7, Betty Diamond8, Soumya Raychaudhuri1, Nir Hacohen9, Anne Davidson10 and Arnon Arazi11, 1Brigham and Women's Hospital, Boston, MA, 2Broad Institute, Boston, MA, 3NYU Grossman School of Medicine, New York, NY, 4University of Rochester Medical Center, Rochester, NY, 5University of Rochester, Rochester, NY, 6Oklahoma Medical Research Foundation, Oklahoma City, OK, 7Johns Hopkins University School of Medicine, Timonium, MD, 8The Feinstein Institutes for Medical Research, Manhasset, NY, 9Broad Institute, Cambridge, MA, 10Feinstein Institutes for Medical Research, Manhasset, NY, 11The Feinstein Institutes for Medical Research, Manhasset

    Background/Purpose: In collaboration with the AMP-RA/SLE network, we identified disease-associated macrophages (D-Macs) in kidney biopsies from 155 patients with active lupus nephritis (LN) and 30…
  • Abstract Number: 0925 • ACR Convergence 2025

    Pathogenic role of SPP1+ macrophages in Rheumatoid Arthritis

    Megan M. Hanlon1, Catherine Manning1, Kevin Wei1, Ursula Fearon2 and Ellen M. Gravallese3, 1Brigham and Women's Hospital at Harvard Medical School, Boston, MA, 2Trinity College Dublin, Dublin, Dublin, Ireland, 3Brigham and Women's Hospital, Harvard Medical School, Chestnut Hill, MA

    Background/Purpose: Synovial tissue macrophages (STMs) represent a mixed population of cells contributing to the pathogenesis of rheumatoid arthritis (RA). We identified an enrichment of Secreted…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 14
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology